The PharmaJet vision is to enable greater access to life-saving vaccines and pharmaceuticals globally. We are committed to helping our partners realize their research and commercialization goals while making an impact on public health. PharmaJet precision delivery systems provide increased vaccine effectiveness, a preferred patient and caregiver experience, and a proven path to commercialization. They are also safe, fast, and easy-to-use. The Stratis system has U.S. FDA 510(k) marketing clearance, CE mark, and WHO PQS certification to deliver medications and vaccines either intramuscularly or subcutaneously. The Tropis system has CE mark and WHO PQS certification for intradermal injections. They are both commercially available for global immunization programs.
Something looks off?